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Dear Editor, 
 The timely publication by Haddad et al. entitled “Transcatheter Aortic Valve 
Replacement in Patients with Pure Native Aortic Valve Regurgitation: A Systematic 
Review and Meta-analysis” in the journal Clinical Cardiology addresses one of the topics 
which is receiving increasing attention in cardiovascular intervention field [1].  
Efforts continue in order to enhance the technical feasibility and improve the clinical 
efficacy of transcatheter techniques for aortic valve replacements in inoperable patients with 
native valve insufficiency or degenerated bioprosthetic valves [2-3]. Furthermore, with the 
advent of the second-generation transcatheter aortic valves, the indication for transcatheter aortic 
valve replacement (TAVR) will be potentially expanding. Nevertheless, appropriate patient 
selection, optimal preoperative risk assessment, and effective postoperative care are mandatory 
measures to achieve a successful TAVR in patients who have been deemed contraindicated for 
surgical AVR due to a high-risk for postoperative morbidity and mortality.   
In order to evaluate 30-day mortality in patients with pure native degenerative aortic 
regurgitation undergoing TAVR, Haddad et al. performed a meta-analysis of 12 studies 
encompassing 638 patients [1]. All-cause 30-day mortality was pooled at 11% (95% CI: 7%-
16%; I2= 20.86%), with a sub-group analysis revealing such a rate at 15% (95% CI: 10%-20%; 
I2= 10%) and 7% (95% CI: 3%-13%; I2= 37%) for the first-generation and second-generation 
aortic valves, respectively. Furthermore, a sub-group interaction analysis showed a success rate 
of 92% for the second-generation aortic valves versus 68% for the first-generation valves.  
A multivariate analysis of the French Aortic National CoreValve and Edwards (FRANCE 
2) has demonstrated that a larger logistic EuroSCORE, TAVR approach (transapical vs. 
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transfemoral), and periprosthetic regurgitation grade of 2 or more are independent predictors of 
1-year mortality after Transcatheter aortic-valve implantation in elderly with aortic stenosis [4]. 
The meta-analysis by Haddad et al. could have taken these determinants into consideration and 
performed a sub-group analysis based on preoperative logistic EuroSCORE. Moreover, the 
authors could elaborate more on the different success rate between the 1st and the 2nd generation 
aortic valves by stratifying the patients based on the preoperative risk score. 
Meta-analysis is a useful tool for summarizing data of the independent studies by 
increasing the statistical power to pool the data for the outcome of interest while controlling for 
the false positive results [5]. Although there are multiple approaches to combine the data from 
different studies, they share a mutual feature which is giving a proportional weight to the data on 
each variable based on the study sample size and the reported variance. The so-called weighted 
average aims to calculate the average of a set of values based on their level of significance and 
relevance. 
As discussed above, it seems interesting that Haddad et al. would assign appropriate 
weight to the reported all-cause 30-day mortality based on the average EuroSCORE by each 
study. If done so, the authors could more realistically interpret the pooled data on 30-day 
mortality following TAVR, given the fact that the EuroSCORE in the study population widely 
ranged from 18.2 to 33% which puts a huge variability between the studies in terms of the 
reported risk for all-cause 30-day mortality rate. 
In summary, we believe that postoperative 30-day mortality in patients with different 
baseline risk categories should be interpreted based on their preoperative surgical risk for TAVR. 
With that being said, patients with aortic valve pathologies undergoing surgical or endovascular 
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interventions should be weighted differently based on their EuroSCORE, when evaluated for 
post-procedure outcome of interest.  
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